Pacific Biosciences Of California Net Profit Margin 2010-2024 | PACB
Pacific Biosciences Of California net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Pacific Biosciences Of California Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $0.17B | $-0.39B | -227.75% |
| 2024-06-30 | $0.19B | $-0.40B | -211.64% |
| 2024-03-31 | $0.20B | $-0.30B | -147.76% |
| 2023-12-31 | $0.20B | $-0.31B | -152.74% |
| 2023-09-30 | $0.17B | $-0.31B | -181.76% |
| 2023-06-30 | $0.15B | $-0.32B | -218.49% |
| 2023-03-31 | $0.13B | $-0.32B | -240.60% |
| 2022-12-31 | $0.13B | $-0.31B | -246.46% |
| 2022-09-30 | $0.14B | $-0.30B | -219.12% |
| 2022-06-30 | $0.14B | $-0.20B | -146.76% |
| 2022-03-31 | $0.14B | $-0.17B | -128.89% |
| 2021-12-31 | $0.13B | $-0.18B | -137.40% |
| 2021-09-30 | $0.12B | $-0.04B | -29.51% |
| 2021-06-30 | $0.11B | $-0.08B | -72.64% |
| 2021-03-31 | $0.09B | $-0.06B | -64.13% |
| 2020-12-31 | $0.08B | $0.03B | 36.71% |
| 2020-09-30 | $0.08B | $-0.05B | -57.50% |
| 2020-06-30 | $0.08B | $-0.05B | -61.45% |
| 2020-03-31 | $0.09B | $-0.05B | -58.24% |
| 2019-12-31 | $0.09B | $-0.08B | -92.31% |
| 2019-09-30 | $0.08B | $-0.12B | -138.55% |
| 2019-06-30 | $0.08B | $-0.11B | -140.51% |
| 2019-03-31 | $0.08B | $-0.11B | -143.42% |
| 2018-12-31 | $0.08B | $-0.10B | -130.38% |
| 2018-09-30 | $0.08B | $-0.09B | -110.71% |
| 2018-06-30 | $0.09B | $-0.09B | -100.00% |
| 2018-03-31 | $0.09B | $-0.09B | -105.68% |
| 2017-12-31 | $0.09B | $-0.09B | -98.94% |
| 2017-09-30 | $0.10B | $-0.09B | -95.79% |
| 2017-06-30 | $0.10B | $-0.09B | -89.58% |
| 2017-03-31 | $0.10B | $-0.08B | -80.41% |
| 2016-12-31 | $0.09B | $-0.07B | -80.22% |
| 2016-09-30 | $0.10B | $-0.06B | -54.46% |
| 2016-06-30 | $0.09B | $-0.04B | -40.00% |
| 2016-03-31 | $0.09B | $-0.03B | -31.91% |
| 2015-12-31 | $0.09B | $-0.03B | -33.33% |
| 2015-09-30 | $0.07B | $-0.05B | -66.22% |
| 2015-06-30 | $0.08B | $-0.06B | -74.07% |
| 2015-03-31 | $0.07B | $-0.07B | -100.00% |
| 2014-12-31 | $0.06B | $-0.07B | -108.20% |
| 2014-09-30 | $0.05B | $-0.06B | -120.75% |
| 2014-06-30 | $0.04B | $-0.08B | -192.31% |
| 2014-03-31 | $0.03B | $-0.08B | -223.53% |
| 2013-12-31 | $0.03B | $-0.08B | -278.57% |
| 2013-09-30 | $0.03B | $-0.08B | -332.00% |
| 2013-06-30 | $0.02B | $-0.09B | -409.52% |
| 2013-03-31 | $0.02B | $-0.09B | -400.00% |
| 2012-12-31 | $0.03B | $-0.10B | -365.38% |
| 2012-09-30 | $0.03B | $-0.10B | -300.00% |
| 2012-06-30 | $0.04B | $-0.10B | -255.00% |
| 2012-03-31 | $0.04B | $-0.10B | -231.82% |
| 2011-12-31 | $0.03B | $-0.11B | -320.59% |
| 2011-09-30 | $0.02B | $-0.12B | -554.55% |
| 2011-06-30 | $0.01B | $-0.13B | -1218.18% |
| 2011-03-31 | $0.00B | $-0.15B | -14500.00% |
| 2010-12-31 | $0.00B | $-0.14B | -7000.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.485B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.728B | 99.43 |
| Thermo Fisher Scientific (TMO) | United States | $203.054B | 24.28 |
| Alcon (ALC) | Switzerland | $44.175B | 29.56 |
| Edwards Lifesciences (EW) | United States | $44.040B | 28.50 |
| IDEXX Laboratories (IDXX) | United States | $36.929B | 42.27 |
| DexCom (DXCM) | United States | $35.044B | 54.35 |
| IQVIA Holdings (IQV) | United States | $34.605B | 19.17 |
| Mettler-Toledo (MTD) | United States | $27.253B | 31.66 |
| Waters (WAT) | United States | $22.442B | 31.84 |
| STERIS (STE) | Ireland | $21.752B | 24.88 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.619B | 0.00 |
| Hologic (HOLX) | United States | $14.406B | 15.55 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.626B | 13.99 |
| Penumbra (PEN) | United States | $11.700B | 105.84 |
| Sysmex ADR (SSMXY) | Japan | $11.461B | 35.94 |
| Globus Medical (GMED) | United States | $11.450B | 29.00 |
| Masimo (MASI) | United States | $9.607B | 46.48 |
| Glaukos (GKOS) | United States | $8.854B | 0.00 |
| Teleflex (TFX) | United States | $8.119B | 12.95 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.507B | 0.00 |
| Veracyte (VCYT) | United States | $3.264B | 97.93 |
| Nihon Kohden (NHNKY) | Japan | $2.704B | 14.78 |
| TransMedics (TMDX) | United States | $2.665B | 84.49 |
| LivaNova (LIVN) | United Kingdom | $2.580B | 14.89 |
| Elekta AB (EKTAY) | Sweden | $2.326B | 20.91 |
| Tandem Diabetes Care (TNDM) | United States | $2.083B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.749B | 9.14 |
| Alphatec Holdings (ATEC) | United States | $1.540B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.247B | 0.00 |
| RxSight (RXST) | United States | $1.239B | 0.00 |
| Artivion (AORT) | United States | $1.231B | 81.56 |
| OPKO Health (OPK) | United States | $1.167B | 0.00 |
| Paragon 28 (FNA) | United States | $1.090B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
| AxoGen (AXGN) | United States | $0.822B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.816B | 17.84 |
| SiBone (SIBN) | United States | $0.760B | 0.00 |
| IRadimed (IRMD) | United States | $0.719B | 37.83 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.717B | 12.19 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.707B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.626B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.503B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.494B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| AngioDynamics (ANGO) | United States | $0.440B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| CVRx (CVRX) | United States | $0.378B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.365B | 19.61 |
| Anteris Technologies Global (AVR) | Australia | $0.294B | 0.00 |
| Inogen (INGN) | United States | $0.254B | 0.00 |
| Accuray (ARAY) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.209B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.141B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.103B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.094B | 14.27 |
| 908 Devices (MASS) | United States | $0.093B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.61 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.041B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |